Cargando…
LRP1 as a promising therapeutic target for gastrointestinal tumors: Inhibiting proliferation, invasion and migration of cancer cells
Gastrointestinal (GI) cancers are the most common types of tumors worldwide. The lack of cancer biomarkers and targeted drug resistance are barriers to achieving effective cancer therapy. Low-density lipoprotein receptor-related protein 1 (LRP1) is a transmembrane protein that has multiple functions...
Autores principales: | Zhu, Mengying, Shen, Hao, Wang, Bili, He, Yingfei, Chen, Jin, Ren, Jun, Zhang, Zhezhong, Jian, Xu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10472044/ https://www.ncbi.nlm.nih.gov/pubmed/37664649 http://dx.doi.org/10.3892/ol.2023.14019 |
Ejemplares similares
-
LRP6 is involved in the proliferation, migration and invasion of trophoblast cells via miR-346
por: Zhang, Lu, et al.
Publicado: (2020) -
Oridonin overcomes the gemcitabine resistant PANC-1/Gem cells by regulating GST pi and LRP/1 ERK/JNK signalling
por: Wang, Bili, et al.
Publicado: (2019) -
TUFM-knockdown inhibits the migration and proliferation of gastrointestinal stromal tumor cells
por: Weng, Xiaoyuan, et al.
Publicado: (2020) -
Inactivation of Wnt-LRP5 signaling suppresses the proliferation and migration of ovarian cancer cells
por: Hong, Jing, et al.
Publicado: (2021) -
The gastrointestinal-brain-microbiota axis: a promising therapeutic target for ischemic stroke
por: Wei, Yan-hao, et al.
Publicado: (2023)